China Universal Asset Management »

Revolution Medicines shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.0M 32k 32.24
2023-12-31 $543k 19k 28.67
2023-09-30 $78k 2.8k 27.84
2023-06-30 $37k 1.4k 26.56
2023-03-31 $27k 1.2k 22.02
2022-12-31 $21k 902 23.28
2022-09-30 $16k 821 19.49

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Revolution Medicines

Wellington Management Company
Vanguard Group
Nextech Invest
BVF
Casdin Capital
Alphabet
Baker Bros. Advisors
Bellevue Group
T. Rowe Price Associates
Jpmorgan Chase & Co
Boxer Capital
Arch Venture Corp
Deerfield Management Company
Holocene Advisors
Henderson Group

View all funds holding Revolution Medicines